MedImmune competitorsClear all

MedImmune's top competitors include U.S. Stem Cell, Endologix, Cannabis Sativa and Pfenex.
MedImmune
MedImmune
MedImmune is a biologics research and development company.
U.S. Stem Cell
U.S. Stem Cell
U.S. Stem Cell is a biotechnology company focused on the discovery, development and, subject to regulatory approval, commercialization of autologous cell therapies for the treatment of chronic and acute heart damage.
Endologix
Endologix
Endologix is a developer and manufacturer of minimally invasive treatments for aortic disorders.
Cannabis Sativa
Cannabis Sativa
Cannabis Sativa, Inc is engaged in the research, development and licensing of specialized natural cannabis products, including cannabis formulas, edibles, topicals, strains, recipes and delivery systems.
Pfenex
Pfenex
Pfenex is a clinical-stage biotechnology company developing and commercializing high-value and difficult to manufacture proteins.
Founding Date
Founding Date
1987
Founding Date
N/A
Founding Date
1992
Founding Date
2012
Founding Date
2009
Type
Type
Subsidiary
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Gaithersburg, US HQ
Great Abington, GB
Mountain View, US
Locations
Sunrise, US HQ
Sunrise, US
Locations
Irvine, US HQ
Rosmalen, NL
's Hertogenbosch, NL
Singapore, SG
Santa Rosa, US
Locations
Mesquite, US HQ
Locations
San Diego, US HQ
Employees
Employees
2,3772% decrease
Employees
10
Employees
52822% decrease
Employees
6
Employees
836% increase
Valuation ($)
Valuation ($)
N/A
Valuation ($)
1.8 m
Valuation ($)
4.2 m
Valuation ($)
9.3 m
Valuation ($)
435.2 m
Twitter followers
Twitter followers
29.4 k
Twitter followers
1.8 k
Twitter followers
602
Twitter followers
129
Twitter followers
4.2 k
Alexa Website Rank
Alexa Website Rank
N/A
Alexa Website Rank
299731
Alexa Website Rank
150587
Alexa Website Rank
337185
Alexa Website Rank
428067
Employee Rating
Employee Rating
3.7
Employee Rating
N/A
Employee Rating
2.8
Employee Rating
N/A
Employee Rating
2.6

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$6.7m (FY, 2018)
Revenue (est.)
$143.4m (FY, 2019)
Revenue (est.)
$1.2m (FY, 2019)
Revenue (est.)
$50.3m (FY, 2019)
Cost of goods
Cost of goods
N/A
Cost of goods
$2.1m (FY, 2018)
Cost of goods
$52.3m (FY, 2019)
Cost of goods
$462.9k (FY, 2019)
Cost of goods
$4.9m (FY, 2019)
Gross profit
Gross profit
N/A
Gross profit
$4.6m (FY, 2018)
Gross profit
$91.1m (FY, 2019)
Gross profit
$696.8k (FY, 2019)
Gross profit
$45.4m (FY, 2019)
Net income
Net income
N/A
Net income
($2.2m) (FY, 2018)
Net income
($64.8m) (FY, 2019)
Net income
($4m) (FY, 2019)
Net income
$1.1m (FY, 2019)
For sources of this data, please see the company profile

View company profiles

U.S. Stem Cell
HQ
Sunrise, US
Employees
10

U.S. Stem Cell is a biotechnology company focused on the discovery, development and, subject to regulatory approval, commercialization of autologous cell therapies for the treatment of chronic and acute heart damage.

View company
Endologix
HQ
Irvine, US
Employees
528↓ 22% decrease

Endologix is a developer and manufacturer of minimally invasive treatments for aortic disorders.

View company
Cannabis Sativa
HQ
Mesquite, US
Employees
6

Cannabis Sativa, Inc is engaged in the research, development and licensing of specialized natural cannabis products, including cannabis formulas, edibles, topicals, strains, recipes and delivery systems.

View company
Pfenex
HQ
San Diego, US
Employees
83↑ 6% increase

Pfenex is a clinical-stage biotechnology company developing and commercializing high-value and difficult to manufacture proteins.

View company